St. George, UT

Chrysalis Clinical Research

Common Cold

Overweight

Obesity

CT-388

Pseudoephedrine

Carmot Therapeutics

Perrigo

condition

allSponsorName

Roche

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants with obesity or who are overweight with at least one weight-related comorbidity.

A Study of CT-388 in Participants with Obesity or Overweight with At Least One Weight-Related Comorbidity

Chrysalis Clinical Research | St. George, UT

Site insights

Work at this site?

Active trials

A Study of CT-388 in Participants with Obesity or Overweight with At Least One Weight-Related Comorbidity

Trial sponsors